Inventor · disambiguated record
Zhi Liu
Also filed as: LIU ZHI · LIU ZHI-REN
31 granted patents·17 pending applications·232 citations·filing 1997–2023
96Inventor score
Files withQILU PUGET SOUND BIOTHERAPEUTICS CORP9AMGEN INC5UNIV GEORGIA STATE RES FOUND5UNIV WASHINGTON5PRODA BIOTECH LLC4
Top patents by PatentIndex Score
48 records- 0195US6746635B2Methods for micronization of hydrophobic drugsUNIV BROWN RES FOUND·Filed 2002·Granted Jun 8, 2004·79 cites·13 claims
- 0293US7078041B2Rapid, efficient purification of HSV-specific T-lymphocytes and HSV antigens identified via sameUNIV WASHINGTON·Filed 2003·Granted Jul 18, 2006·33 cites·11 claims
- 0393US6824791B2Methods for micronization of hydrophobic drugsUNIV BROWN RES FOUND·Filed 2004·Granted Nov 30, 2004·48 cites·22 claims
- 0492US7666434B2Rapid, efficient purification of HSV-specific T-lymphocytes and HSV antigens identified via sameUNIV WASHINGTON·Filed 2008·Granted Feb 23, 2010·15 cites·19 claims
- 0591US8197824B2Rapid, efficient purification of HSV-specific T-lymphocytes and HSV antigens identified via sameKOELLE DAVID M·Filed 2010·Granted Jun 12, 2012·9 cites·20 claims
- 0690US7431934B2Rapid, efficient purification of HSV-specific T-lymphocytes and HSV antigens identified via sameUNIV WASHINGTON·Filed 2006·Granted Oct 7, 2008·5 cites·15 claims
- 0788US9822173B2Heterodimeric immunoglobulinsAMGEN INC·Filed 2013·Granted Nov 21, 2017·10 cites·19 claims
- 0887US11130808B2Mixtures of antibodiesQILU PUGET SOUND BIOTHERAPEUTICS CORP·Filed 2017·Granted Sep 28, 2021·6 cites·21 claims
- 0986US10233237B2Heterodimeric immunoglobulinsAMGEN INC·Filed 2013·Granted Mar 19, 2019·8 cites·16 claims
- 1083US8367040B2Contrast agents and methods for preparing contrast agentsUNIV GEORGIA STATE RES FOUND·Filed 2012·Granted Feb 5, 2013·2 cites·6 claims
- 1183US8173105B2Contrast agents and methods for preparing contrast agentsYANG JENNY J·Filed 2006·Granted May 8, 2012·2 cites·6 claims
- 1278US11198732B2Fc variantsAMGEN INC·Filed 2019·Granted Dec 14, 2021·1 cites·10 claims
- 1378US11124570B2Anti-PD1 and anti-CTLA4 antibodiesQILU PUGET SOUND BIOTHERAPEUTICS CORP·Filed 2017·Granted Sep 21, 2021·1 cites·12 claims
- 1476US8524829B2Methods for micronization of hydrophobic drugsMATHIOWITZ EDITH·Filed 2008·Granted Sep 3, 2013·2 cites·13 claims
- 1573US7741066B2Phosphorylated p68 RNA helicase as a marker for cancer and cancer metastasisLIU ZHI-REN·Filed 2006·Granted Jun 22, 2010·4 cites·9 claims
- 1671US2020108158A1Targeted contrast agents and methods for targeting contrast agentsUNIV GEORGIA STATE RES FOUND·Filed 2019·Application pending·0 cites
- 1770US12410230B2Anti-angiogenic agent and methods of using such agentGEORGIA STATE UNIV RESEARCH FOUNDATION·Filed 2023·Granted Sep 9, 2025·0 cites·17 claims
- 1869US9339559B2Targeted contrast agents and methods for targeting contrast agentsYANG JENNY J·Filed 2006·Granted May 17, 2016·0 cites·22 claims
- 1967US11466078B2Heterodimeric immunoglobulinsAMGEN INC·Filed 2019·Granted Oct 11, 2022·0 cites·7 claims
- 2066US12037397B2Anti-PD1 and anti-CTLA4 antibodiesQILU PUGET SOUND BIOTHERAPEUTICS CORP·Filed 2021·Granted Jul 16, 2024·0 cites·9 claims
- 2166US9675688B2Rapid, efficient purification of HSV-specific T-lymphocytes and HSV antigens identified via sameUNIV WASHINGTON·Filed 2015·Granted Jun 13, 2017·0 cites·13 claims
- 2265US2013189294A1Rapid, efficient purification of hsv-specific t-lymphocytes and hsv antigens identified via sameUNIV WASHINGTON·Filed 2013·Application pending·0 cites
- 2364US10525150B2Targeted contrast agents and methods for targeting contrast agentsUNIV GEORGIA STATE RES FOUND·Filed 2016·Granted Jan 7, 2020·0 cites·8 claims
- 2464US9138473B2Rapid, efficient purification of HSV-specific T-lymphocytes and HSV antigens identified via sameKOELLE DAVID M·Filed 2012·Granted Sep 22, 2015·0 cites·13 claims
- 2563US12441816B2Heterodimeric Fc for making fusion proteins and bispecific antibodiesQILU PUGET SOUND BIOTHERAPEUTICS CORP·Filed 2022·Granted Oct 14, 2025·0 cites·46 claims
- 2662US2025387390A1Methods for treating fibrosis using pkm2 activatorsPRODA BIOTECH L L C·Filed 2022·Application pending·0 cites
- 2761US2022073615A1Mixtures of antibodiesQILU PUGET SOUND BIOTHERAPEUTICS CORP·Filed 2021·Application pending·0 cites
- 2860US10213493B2Protein to promote blood vessel growth and uses thereofGEORGIA STATE UNIV RESEARCH FOUNDATION·Filed 2013·Granted Feb 26, 2019·1 cites·13 claims
- 2958US2025197503A1ANTI-HUMAN PD-Ll AND TLR7 DOUBLE-TARGETING NANOBODY CONJUGATE DRUG AND USE THEREOF IN RESISTING TUMORSHANGHAI INST MATERIA MEDICA CAS·Filed 2023·Application pending·0 cites
- 3058US2005100595A1Methods for micronization of hydrophobic drugsUNIV BROWN RES FOUND·Filed 2004·Application pending·0 cites
- 3157US2024173353A1Universal chimeric antigen receptor t-cell and application thereofSHANGHAI IASO BIOTECHNOLOGY CO LTD·Filed 2022·Application pending·0 cites
- 3257US2022267446A1Combinations of anti-pd1 and anti-ctla4 antibodiesQILU PUGET SOUND BIOTHERAPEUTICS CORP·Filed 2022·Application pending·0 cites
- 3355US2023279130A1Anti-ccr8 antibodiesQILU PUGET SOUND BIOTHERAPEUTICS CORP·Filed 2023·Application pending·0 cites
- 3451US11578114B2Anti-angiogenic agent and methods of using such agentGEORGIA STATE RES FOUNDATION·Filed 2015·Granted Feb 14, 2023·0 cites·13 claims
- 3551US2024059785A1Anti-cd20 antibodies, anti-cd37 antibodies, and mixtures thereofQILU PUGET SOUND BIOTHERAPEUTICS CORP·Filed 2020·Application pending·0 cites
- 3650US12447199B2System and methods to promote cellular regeneration following ischemiaUNIV GEORGIA STATE RES FOUND·Filed 2018·Granted Oct 21, 2025·0 cites·8 claims
- 3750US2014112926A1Fc VARIANTSLIU ZHI·Filed 2012·Application pending·0 cites
- 3848US9175063B2Anti-angiogenic agent and methods of using such agentLIU ZHI-REN·Filed 2011·Granted Nov 3, 2015·0 cites·9 claims
- 3947US11459364B2Calbindin and BH3 domain chimeric proteins and methods for usePRODA BIOTECH LLC·Filed 2015·Granted Oct 4, 2022·0 cites·8 claims
- 4042US2022235144A1Anti-sirp-alpha antibodiesQILU PUGET SOUND BIOTHERAPEUTICS CORP·Filed 2020·Application pending·0 cites
- 4141US2023137351A1Bispecific or biparatopic antigen binding proteins and uses thereofAMGEN INC·Filed 2017·Application pending·0 cites
- 4240US11214624B2Method to prevent cancer metastasis and inhibit inflammation by inhibition of p68 interaction with calmodulinPRODA BIOTECH LLC·Filed 2013·Granted Jan 4, 2022·0 cites·7 claims
- 4340US8697648B2Protein agent for diabetes treatment and β cell imagingLIU ZHI-REN·Filed 2010·Granted Apr 15, 2014·0 cites·12 claims
- 4436US2002055622A1Mammalian non-erythroid Rh type C genes and glycoproteinsFiled 2001·Application pending·0 cites
- 4535US2018044403A1Integrin-targeting protein and methods of use thereofUNIV GEORGIA STATE RES FOUND·Filed 2016·Application pending·0 cites
- 4631US2016002347A1Pyruvate kinase m2 neutralizing antibodies for inhibiting angiogenesisPRODA BIOTECH LLC·Filed 2013·Application pending·0 cites
- 4730US5811307ADicationic perylene dye for precipitation and quantitation of DNAUNIV FLORIDA STATE·Filed 1997·Granted Sep 22, 1998·6 cites·3 claims
- 4823US2018072812A1Molecules disrupting pyruvate kinase m2 and integrin interaction and uses thereofPRODA BIOTECH LLC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Zhi Liu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →